131 results
Page 4 of 7
8-K
EX-10.1
fjdr04d1vx gzyza2
31 Aug 20
Hoth Therapeutics Appoints Dr. Stefanie Johns, Ph.D., as Chief Scientific Officer
4:25pm
8-K
EX-10.1
fz05pl21a3r
5 Aug 20
Hoth Therapeutics’ Executes Licensing Agreement of VNLG-152 for Treatment of Dermatological Diseases
4:13pm
8-K
yd8yiko1ue3zp99q6o
5 Aug 20
Hoth Therapeutics’ Executes Licensing Agreement of VNLG-152 for Treatment of Dermatological Diseases
4:13pm
8-K
EX-10.1
exizg 364oc
2 Jul 20
Hoth Therapeutics Announces Sponsored Research Agreement with VCU for Potential COVID-19 Treatment
8:00am
424B5
n025e8w 07b1
22 May 20
Prospectus supplement for primary offering
4:35pm
8-K
EX-1.1
76yx7
22 May 20
Hoth Announces Pricing of Public Offering of Shares of Common Stock
4:05pm
424B5
h25 hsai7
21 May 20
Prospectus supplement for primary offering
4:40pm
8-K
gr5w76x
21 May 20
Hoth Announces Proposed Public Offering of Common Stock
4:02pm
8-K
EX-99.2
0rp3cc6k8kf6enq6g
21 May 20
Hoth Announces Proposed Public Offering of Common Stock
4:02pm
DEF 14A
rdmwxdaovzuis qa
19 May 20
Definitive proxy
4:17pm
424B3
6u3d666e57oroxvsmlj
7 May 20
Prospectus supplement
6:02am
424B5
9l6ilf9c9ebezmp9
25 Mar 20
Prospectus supplement for primary offering
4:31pm
8-K
EX-1.1
0qr5x9jtb5
25 Mar 20
Hoth Announces Proposed Public Offering of Common Stock
4:15pm
424B5
tgzp brausggj4y
23 Mar 20
Prospectus supplement for primary offering
5:13pm
8-K
kw68wgm
23 Mar 20
Entry into a Material Definitive Agreement
5:10pm